One 35 year old friend of mine was on oxygen for four months and out of work for six months.
Another’s (31) autonomic nervous system is fried and needs to be on vasoconstrictor drugs so she does not faint every time she stands up.
Four more in their thirties fought it off like a horrible flu plus smell issues.
There is evidence that the immunity provided by the RNA vaccines is stronger and possibly more reliable than that produced by natural infection for 3⁄4 of the population.
There is evidence of very weird and interesting infection of cardiac cells early in infection with implications that are not understood and might have interesting effects forty years down the line. Precautionary.
I also do not want to spread to people around me who are unvaccinated.
On another note, I remain flabbergasted and angry that very little research is going on in Europe and America about indomethacin and ivermectin.
I strong-upvoted this comment from CheerfulWarrior, to bring it from the negatives to the positives. I think CellBioGuy’s comment was good, and a valuable contribution to the discussion. I think it’s also useful for CheerfulWarrior to ask for citations, and useful to remind us of the risk of anecdotes here: we should share data like this, but it’s true that there are meaningful risks of mis-reporting, of selection effects, and of over-updating-due-to-emotional-salience.
E.g., imagine 99⁄100 LessWrongers deciding not to comment because they haven’t heard of their friends suffering long-term effects, while the 1⁄100 LWer whose friends are seeing serious sequelae does decide to comment, since they have the more interesting story to tell.
(I’m making these points as a procedural point, not because I disagree with CellBioGuy’s conclusions. In this case, I do think long-term effects of COVID are not-super-rare in 30-50-year-olds, based on a variety of cobbled-together sources of varying quality, and based on first- and second-hand reports from my friends, people I follow on Twitter, etc.)
(Added: The tone is maybe not optimally friendly, but I think it’s better to focus on epistemic content in this context.)
One 35 year old friend of mine was on oxygen for four months and out of work for six months.
Another’s (31) autonomic nervous system is fried and needs to be on vasoconstrictor drugs so she does not faint every time she stands up.
Four more in their thirties fought it off like a horrible flu plus smell issues.
There is evidence that the immunity provided by the RNA vaccines is stronger and possibly more reliable than that produced by natural infection for 3⁄4 of the population.
There is evidence of very weird and interesting infection of cardiac cells early in infection with implications that are not understood and might have interesting effects forty years down the line. Precautionary.
I also do not want to spread to people around me who are unvaccinated.
On another note, I remain flabbergasted and angry that very little research is going on in Europe and America about indomethacin and ivermectin.
ąnecdotes from a stranger on the Internet.
[citation needed]
I strong-upvoted this comment from CheerfulWarrior, to bring it from the negatives to the positives. I think CellBioGuy’s comment was good, and a valuable contribution to the discussion. I think it’s also useful for CheerfulWarrior to ask for citations, and useful to remind us of the risk of anecdotes here: we should share data like this, but it’s true that there are meaningful risks of mis-reporting, of selection effects, and of over-updating-due-to-emotional-salience.
E.g., imagine 99⁄100 LessWrongers deciding not to comment because they haven’t heard of their friends suffering long-term effects, while the 1⁄100 LWer whose friends are seeing serious sequelae does decide to comment, since they have the more interesting story to tell.
(I’m making these points as a procedural point, not because I disagree with CellBioGuy’s conclusions. In this case, I do think long-term effects of COVID are not-super-rare in 30-50-year-olds, based on a variety of cobbled-together sources of varying quality, and based on first- and second-hand reports from my friends, people I follow on Twitter, etc.)
(Added: The tone is maybe not optimally friendly, but I think it’s better to focus on epistemic content in this context.)